BSE filing, NSE: SAURASHCEM. Summary written from the filing by ALFA Finder's alert engine.
Saurashtra Cements Ltd: key numbers
- Share price
- ₹47.10
- Market cap
- ₹524.2 Cr
- Revenue (annual)
- ₹1,666 Cr
- Net profit (annual)
- ₹14.42 Cr
- P/E (TTM)
- 78.3×Sector 31.7×
- Promoter holding
- 66.62%+0.00% QoQ
- FII holding
- 0.01%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Saurashtra Cements Ltd
All →Saurashtra Cements Board Meeting Date
Saurashtra Cement Ltd will hold a board meeting on 4th November 2026 to consider and approve its unaudited financial results for the quarter ended September 2026.
Saurashtra Cements Management Change
Saurashtra Cement Ltd appointed Mr. Anurag Tiwari as Managing Director-Designate, effective 16th October 2026. This appointment is classified under Senior Management Personnel.
Saurashtra Cements Legal & Regulatory
Saurashtra Cement received a GST show cause notice from the Deputy Commissioner of State Tax demanding ₹3.83 Crore, which the company intends to contest.
- Value
- ₹3.83 Cr
Saurashtra Cements Credit Rating
ICRA Limited has reaffirmed the credit rating of [ICRA] BBB- (Stable) for bank facilities of Saurashtra Cement Limited aggregating to ₹404 Crore.
Saurashtra Cements Business Update
Saurashtra Cement signed a Power Consumption Agreement and Share Purchase Agreement with Jamnagar Renewables Two Private Limited, acquiring an 8.86% stake for Rs 14.92 Crore.
- Value
- ₹14.92 Cr
- From
- Jamnagar Renewables Two Private Limited
- Execution
- 25 years
- Wind-Solar Hybrid power
- 14.0 MW
Saurashtra Cements Business Update
Saurashtra Cement entered a Power Consumption and Shareholders' Agreement with Jamnagar Renewables Two for sourcing 14 MW of wind-solar hybrid power under a group captive arrangement.
- Execution
- 25 years
- Wind–Solar Hybrid power
- 14.0 MW
Other other announcement announcements
All →Aarti Pharmalabs Other Announcement
Aarti Pharmalabs has intimated under Regulation 46 that it revamped its website at the existing URL to improve design and accessibility. The notice has no financial or business substance.
Sagarsoft (India) Other Announcement
Sagarsoft (India) filed its Regulation 32 fund utilisation statement for its 2021 preferential issue. No deviation was reported and the full Rs.5.08 Crore was used.
Sadhana Nitro Chem Other Announcement
Sadhana Nitro Chem reported no deviation in use of its preferential issue proceeds for the quarter ended September 2026. The Audit Committee reviewed the statement.
Shriram Asset Management Company Other Announcement
Shriram AMC filed ICRA's quarterly monitoring agency report on preferential issue proceeds. Utilisation is in line with the offer objects, with no deviation reported.
Jhandewalas Foods Other Announcement
Jhandewalas Foods filed its quarterly shareholding pattern for the period ended September 30, 2026. The filing records holdings by category and contains no transaction or money event.
Avience Biomedicals Other Announcement
Avience Biomedicals confirmed corporate governance compliance is not applicable, as it is SME-listed on NSE Emerge. No quarterly governance report is required for September 2026.